HD: Hemodialysis; MR-proADM: Mid-region proadrenomedullin; n.s: No significant differences.
Figure 2: Plasma concentrations of presepsin (A) MR-proADM (B) and procalcitonin (C) in patients with end-stage renal disease before and after hemodialysis (HD) following cardiovascular surgery.